| The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma J Liu, G Ren, K Li, Z Liu, Y Wang, T Chen, W Mu, X Yang, X Li, A Shi, ... Cell Death & Differentiation 29 (4), 818-831, 2022 | 35 | 2022 |
| Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression Y Wang, K Li, W Zhao, Z Liu, J Liu, A Shi, T Chen, W Mu, Y Xu, C Pan, ... Cell Death & Disease 12 (12), 1158, 2021 | 26 | 2021 |
| Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study L Chen, Z Fan, X Sun, W Qiu, W Mu, K Chai, Y Cao, G Wang, G Lv Hepatology International 17 (2), 326-338, 2023 | 21 | 2023 |
| BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner Z Liu, C Hu, L Zheng, J Liu, K Li, X Li, Y Wang, W Mu, T Chen, A Shi, ... Cellular and Molecular Life Sciences 79 (9), 469, 2022 | 21 | 2022 |
| Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma M Jiao, S Ning, J Chen, L Chen, M Jiao, Z Cui, L Guo, W Mu, H Yang International Journal of Oncology 56 (6), 1455-1467, 2020 | 21 | 2020 |
| Associations of cholecystectomy with the risk of colorectal cancer: a Mendelian randomization study L Chen, Z Fan, X Sun, W Qiu, W Mu, K Chai, Y Cao, G Wang, G Lv Chinese Medical Journal 136 (07), 840-847, 2023 | 12 | 2023 |
| From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification Z Fan, M Jin, L Zhang, N Wang, M Li, C Wang, F Wei, P Zhang, X Du, ... Gut 72 (11), 2149-2163, 2023 | 8 | 2023 |
| Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study L Chen, Z Fan, X Sun, W Qiu, W Mu, K Chai, Y Cao, G Wang, G Lv Frontiers in pharmacology 13, 900424, 2022 | 8 | 2022 |
| Recent advances in the mechanism research and clinical treatment of anti-angiogenesis in biliary tract cancer Y Wang, T Chen, K Li, W Mu, Z Liu, A Shi, J Liu, W Zhao, S Lian, S Huang, ... Frontiers in Oncology 11, 777617, 2021 | 8 | 2021 |
| Case report: Incidentally discovered a rare cystic lesion of liver: Multicystic biliary hamartoma W Mu, P Su, S Ning Pathology and Oncology Research 27, 2021 | 8 | 2021 |
| Long Noncoding RNA SNHG1 Regulates LMNB2 Expression by Sponging miR-326 and Promotes Cancer Growth in Hepatocellular Carcinoma W Mu, L Guo, Y Liu, H Yang, S Ning, G Lv Frontiers in Oncology 11, 784067, 2021 | 7 | 2021 |
| Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells W Mu, Y Zhi, J Zhou, C Wang, K Chai, Z Fan, G Lv Frontiers in Pharmacology 15, 1419468, 2024 | 3 | 2024 |
| Quenching thirst with poison? Paradoxical effect of anticancer drugs K Chai, C Wang, J Zhou, W Mu, M Gao, Z Fan, G Lv Pharmacological Research, 106987, 2023 | 3 | 2023 |
| Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing S Li, Y Zhi, W Mu, M Li, G Lv European Journal of Pharmacology 964, 176300, 2024 | 2 | 2024 |
| Extended high hilar resection and enlarged hepatic portal enterostomy in the treatment of hilar cholangiocarcinoma AQ Saleh, Y Chen, S Ning, G Lingyu, H Fitrat, M Wentao Age (years) 35, 78, 2020 | | 2020 |
| Involvement of Hereditary Hemorrhagic Telangiectasia (HHT) in kidneys H Fitrat, Y Chen, AQ Saleh, S Ning, S Ismail, M Wentao | | 2020 |
Lanlan ChenCharité - Universitätsmedizin Berlin在 charite.de 的电子邮件经过验证
Lanlan ChenCharité - Universitätsmedizin Berlin在 charite.de 的电子邮件经过验证
Yao ZhiJilin University在 mails.jlu.edu.cn 的电子邮件经过验证